For example, and as mentioned, differences were found in the levels of TPO, HSP60 and MHC-II in circulating EVs from HT patients [73] or of IGF-1R and HSP60 in circulating EVs from GD patients [75] as compared to healthy individuals. This evidence concerns the gene TPO and hematocrit.